Recombinant Glukagon Antibody - Primary antibody, specific to Human, IgG

Features and benefits
  • Short Overview:

    Recombinant (EP3070); Rabbit anti Human Glucagon Antibody; IHC; Unconjugated

  • Species reactivity(Reacts with): Human,Mouse,Rat
  • Isotype: IgG
    Application:
  • IHC
Item Number
Ab105544
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab105544-10μl
10μl
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$66.90
Ab105544-50μl
50μl
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$198.90
Ab105544-100μl
100μl
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$297.90
Ab105544-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,107.90

Recombinant (EP3070); Rabbit anti Human Glucagon Antibody; IHC; Unconjugated

Basic Description

Product NameRecombinant Glukagon Antibody - Primary antibody, specific to Human, IgG
SynonymsGCG antibody
Specifications & PurityExactAb™, Validated, Recombinant, 0.3 mg/mL
Host speciesRabbit
SpecificityHuman
ImmunogenSynthetic peptide within Human Glucagon aa 50-150 (N terminal). The exact sequence is proprietary.
Positive ControlIHC: Human pancreas tissue
ConjugationUnconjugated
GradeExactAb™, Recombinant, Validated
Product Description

Recombinant antibody (EP3070) to Glukagon, could be used for IHC and so on.

Application:
IHC: 1/100-1/200


Purity
Protein A purified

Relevance
Glukagon is a hormone that is secreted by alpha cells in the pancreas. Glukagon antagonizes insulin by converting glycogen to glucose in the liver and increasing blood sugar levels. Glukagon-like peptide 1 (GLP1), Glukagon-like peptide 2 (GLP2), VIP (vasoactive intestinal peptide) and PACAP (pituitary adenylate cyclase activating polypeptide) are in the Glukagons hormone family. GLP1 is a transmitter in the central nervous system that regulates feeding and drinking behavior. GLP2 stimulates intestinal epithelial growth.

Product Properties

IsotypeIgG
SDS-PAGE150 kDa
Purification MethodProtein A purified
FormLiquid
Concentration0.3 mg/mL
Storage TempStore at -20°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

Associated Targets(Human)

GATA4 Tbio Transcription factor GATA-4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GCG Tchem Glucagon (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GCG Tchem Glucagon (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GATA4 Tbio Transcription factor GATA-4 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Application

ApplicationDilution info
IHC

1/100 - 1/200

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeDateItem
ZJ23F0700717Certificate of AnalysisApr 25, 2024 Ab105544
ZJ23F0700718Certificate of AnalysisApr 25, 2024 Ab105544

Related Documents

References

1. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC.  (1983)  Exon duplication and divergence in the human preproglucagon gene..  Nature,  304  (5924): (368-71).  [PMID:6877358]
2. Rouillé Y, Bianchi M, Irminger JC, Halban PA.  (1997)  Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon..  FEBS Lett,  413  (1): (119-23).  [PMID:9287128]
3. Bonic A, Mackin RB.  (2003)  Expression, purification, and PC1-mediated processing of human proglucagon, glicentin, and major proglucagon fragment..  Protein Expr Purif,  28  (1): (15-24).  [PMID:12651102]
4. Kim RM, Chang J, Lins AR, Brady E, Candelore MR, Dallas-Yang Q, Ding V, Dragovic J, Iliff S, Jiang G, Mock S, Qureshi S, Saperstein R, Szalkowski D, Tamvakopoulos C, Tota L, Wright M, Yang X, Tata JR, Chapman K, Zhang BB, Parmee ER..  (2008)  Discovery of potent, orally active benzimidazole glucagon receptor antagonists..  Bioorg Med Chem Lett,  18  (13): (3701-3705).  [PMID:18539028]
5. Orskov, C C, Bersani, M M, Johnsen, A H AH, Højrup, P P and Holst, J J JJ..  (1989)  Complete sequences of glucagon-like peptide-1 from human and pig small intestine..  The Journal of biological chemistry,    (5):   [PMID:2753890]
6. Drucker, D J DJ and Asa, S S..  (1988)  Glucagon gene expression in vertebrate brain..  The Journal of biological chemistry,    (25):   [PMID:2901414]
7. White, J W JW and Saunders, G F GF..  (1986)  Structure of the human glucagon gene..  Nucleic acids research,    (25):   [PMID:3725587]
8. Orskov, C C, Wettergren, A A and Holst, J J JJ..  (1993)  Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable..  Diabetes,      [PMID:8482423]
9. Sturm, N S NS and 7 more authors..  (1998)  Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity..  Journal of medicinal chemistry,    (16):   [PMID:9667960]
10. and Drucker DJ..  (1999)  Glucagon-like Peptide 2..  Trends in endocrinology and metabolism: TEM,      [PMID:10322410]
11. Kieffer, T J TJ and Habener, J F JF..  (1999)  The glucagon-like peptides..  Endocrine reviews,      [PMID:10605628]
12. Chang, Xiaoqing X, Keller, Danielle D, O'Donoghue, Seán I SI and Led, Jens J JJ..  (2002)  NMR studies of the aggregation of glucagon-like peptide-1: formation of a symmetric helical dimer..  FEBS letters,    (27):   [PMID:11943215]
13. Thomsen, J J, Kristiansen, K K, Brunfeldt, K K and Sundby, F F..  (1972)  The amino acid sequence of human glucagon..  FEBS letters,    (1):   [PMID:11946536]
14. and Drucker, Daniel J DJ..  (2003)  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis..  Molecular endocrinology (Baltimore, Md.),      [PMID:12554744]
15. Jiang, Guoqiang G and Zhang, Bei B BB..  (2003)  Glucagon and regulation of glucose metabolism..  American journal of physiology. Endocrinology and metabolism,      [PMID:12626323]
16. Ying, Jinfa J, Ahn, Jung-Mo JM, Jacobsen, Neil E NE, Brown, Michael F MF and Hruby, Victor J VJ..  (2003)  NMR solution structure of the glucagon antagonist [desHis1, desPhe6, Glu9]glucagon amide in the presence of perdeuterated dodecylphosphocholine micelles..  Biochemistry,    (18):   [PMID:12627948]
17. Cohen, Mark A MA and 8 more authors..  (2003)  Oxyntomodulin suppresses appetite and reduces food intake in humans..  The Journal of clinical endocrinology and metabolism,      [PMID:14557443]
18. Tadokoro, R R and 5 more authors..  (2003)  Postnatal and postprandial changes in plasma concentrations of glicentin in term and preterm infants..  Acta paediatrica (Oslo, Norway : 1992),      [PMID:14632334]
19. Brubaker, Patricia L PL and Anini, Younes Y..  (2003)  Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2..  Canadian journal of physiology and pharmacology,      [PMID:14719035]
20. Hillier, Ladeana W LW and 121 more authors..  (2005)  Generation and annotation of the DNA sequences of human chromosomes 2 and 4..  Nature,    (7):   [PMID:15815621]
21. Ellingsgaard, Helga H and 20 more authors..  (2011)  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells..  Nature medicine,    (30):   [PMID:22037645]

Solution Calculators